News US channels $104m into antimicrobial resistance project The US government has set aside a $104 million pot of funding for research into bacterial behaviour and antibiotic resistance, in the hope of speeding up diagnosis and ena
R&D A new approach to drug design: Restoring the effectiveness o... None of us are unaware of the very real danger of ‘superbugs’ – only last month, the hospita
News Shionogi agrees $140m deal to buy antibiotic biotech Qpex While most pharma companies have exited the antibiotics area, Japanese dru
Market Access What happened to all the antibiotics? Across the world, there are reports of shortages of common antibiotics.
News Azithromycin for mild-to-moderate COVID-19 Azithromycin has been widely evaluated for its efficacy against COVID-19.
News The Post-Pandemic World of Antibiotics COVID-19 Antibiotics are cheap and common drugs used to treat bacterial infections.
News AbbVie's Cerevel takeover delivers Parkinson's approval The first drug from AbbVie's $8.7 billion takeover of Cerevel two years ago, Parkinson's disease therapy Juvmo, has won FDA approval.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.